Heterozygous variants in the arginine-glutamic acid dipeptide repeats gene (RERE) have been shown to cause neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (NEDBEH). Here, we report nine individuals with NEDBEH who carry partial deletions or deleterious sequence variants in RERE. These variants were found to be de novo in all cases in which parental samples were available. An analysis of data from individuals with NEDBEH suggests that point mutations affecting the Atrophin-1 domain of RERE are associated with an increased risk of structural eye defects, congenital heart defects, renal anomalies, and sensorineural hearing loss when compared with loss-of-function variants that are likely to lead to haploinsufficiency.
INTRODUCTION
The arginine-glutamic acid dipeptide repeats gene (RERE; MIM# 605226) encodes a widely expressed nuclear receptor coregulator (Wang, Rajan, Pitman, McKeown, & Tsai, 2006; Zoltewicz, Stewart, Leung, & Peterson, 2004) . Acting in a complex with nuclear receptors and other transcription factors, RERE can function to inhibit or promote the expression of individual genes including FGF8 and RARB (Kumar & Duester, 2014; Vilhais-Neto et al., 2010; L. Wang, Charroux, Kerridge, & Tsai, 2008; Zoltewicz et al., 2004) . One of RERE's roles is to positively regulate retinoic acid signaling in multiple tissues during embryonic development (Kumar & Duester, 2014; Vilhais-Neto et al., 2010; Vilhais-Neto et al., 2017) .
The importance of RERE during development was first demonstrated in animal models. Although no abnormal phenotypes have been described in mice that are haploinsufficient for Rere, Zoltewicz et al. (2004) demonstrated that mouse embryos that were homozygous for an Rere null allele (om, c.396+2T>A) died around E9.5 with open neural tube defects and signs suggestive of cardiac failure. A detailed analysis of Rere-null embryos revealed failure of ventralization of the anterior neural plate, fusion of the telencephalic and optic vesicles, failure of heart looping and irregular partitioning of somites. This provided evidence that RERE plays a critical role in brain, eye, and heart development as well as embryonic patterning. Schilling et al. (1996) and Plaster, Sonntag, Schilling, and Hammerschmidt (2007) reported that zebrafish carrying homozygous variants affecting rerea, the zebrafish homologue of RERE, had microphthalmia, inconsistent startle response and decreased microphonic potentials.
This finding provided additional evidence for the role of RERE in eye development and also suggested that RERE may play a role in inner ear development and function.
To overcome the early lethality associated with complete loss of RERE function, Kim et al. (2013) generated an allelic series of mice bearing the om null allele and an eyes3 (c.578T>C, p.(Val193Ala)) hypomorphic allele. Rere om/eyes3 embryos and mice had a variety of abnormal phenotypes including postnatal growth deficiency, brain hypoplasia, decreased numbers of neuronal nuclear antigen (NeuN)-positive hippocampal neurons, abnormal cerebellar morphology, delayed maturation and migration of Purkinje cells, ventriculomegaly, microphthalmia, colobomata, hearing loss, conotruncal and septal congenital heart defects, spontaneous development of cardiac fibrosis, and renal agenesis (Fregeau et al., 2016; Kim & Scott, 2014; Kim et al., 2013) .
Many of the features seen in RERE-deficient mice overlap those associated with 1p36 deletion syndrome (MIM# 607872) in humans, which is characterized by developmental delay, intellectual disability, seizures, vision problems, hearing loss, short stature, distinctive facial features, brain anomalies, orofacial clefting, congenital heart defects, cardiomyopathy, and renal anomalies (Jordan, Zaveri, & Scott, 2015; Kang et al., 2007; Shapira et al., 1997) . Since RERE is located within the proximal 1p36 deletion syndrome critical region, Kim et al. (2013) hypothesized that RERE haploinsufficiency in humans is likely to contribute to many of the phenotypes seen in individuals with terminal and interstitial 1p36 deletions that include RERE (Jordan et al., 2015) . This hypothesis was supported by Fregeau et al. (2016) who identified 10 individuals with intellectual disability, developmental delay and/or autism spectrum disorder that carried rare, heterozygous putatively damaging sequence variants in RERE. These variants were found to be de novo in all cases in which parental DNA samples were available. Neurocognitive deficits, hypotonia, seizures, behavioral problems, structural brain anomalies, ophthalmologic anomalies, congenital heart defects, and genitourinary abnormalities were recurrently documented within this cohort. The genetic syndrome found in these individuals was subsequently described as neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (NEDBEH; MIM# 616975).
Here, we describe nine unrelated individuals with NEDBEH caused by partial deletions or putatively deleterious sequence variants in
RERE. An analysis of clinical and molecular data from individuals with NEDBEH suggests the existence of novel genotype-phenotype correlations and demonstrates that a high percentage of RERE pathogenic variants affect a histidine-rich region in the Atrophin-1 domain. We document two individuals who carry a recurrent two-amino-acid duplication in this region who fulfill diagnostic criteria for CHARGE syndrome (MIM# 214800) but do not carry pathogenic variants in CHD7 (MIM # 608892).
MATERIALS AND METHODS

Subject accrual
All subjects or their parents/guardians provided informed consent and were enrolled in institutional review board-approved research studies.
In all cases, the procedures followed were in accordance with the ethical standards of the institution's committee on human research and were in keeping with international standards.
Copy number variant analysis
The RERE deletion in Subject 1 was identified by array-based copy number variant (CNV) analysis performed on a clinical basis at Baylor Genetics. This analysis was performed using a custom-designed oligonucleotide-based array that included 400,000 probes for the detection of gains or losses of genomic material via array-based comparative genomic hybridization and 60,000 SNP probes for the detection of absence of heterozygosity (Wiszniewska et al., 2014) .
Exome sequencing
Exome sequencing was performed for all subjects in CLIA or ISO15189 certified laboratories with the exception of Subject 2 whose exome sequencing was performed on a research basis. For Subject 2, trio exome sequencing was performed on a HiSeq2500 platform (Illumina, San Diego, CA). Library preparation was performed using a KAPA Biosystems (Wilmington, MA) library preparation kit followed by whole exome capture using a Roche NimbleGen (Madison, WI) SeqCap EZ Exome Kit v3.0/v4.0. Bioinformatic processing was performed by Colombia University's Institute for Genomic Medicine using established bioinformatic and trio analysis platforms. All sequence variants described in this manuscript were confirmed by Sanger sequencing.
Throughout the text and tables, nucleotide (cDNA) numbering uses 
In silico prediction of the effects of sequence variants
The following programs were used to predict the effects of sequence variants on protein function: PolyPhen-2 [HumVar] (https://genetics.bwh.harvard.edu/pph2/), SIFT (https://sift.jcvi.org/), and MutationTaster (https://www.mutationtaster.org/). 
Statistical analysis
RESULTS
Here, we describe nine individuals who carry partial deletions or putatively deleterious sequence variants in RERE (Figure 1 
Subject 1
Subject 1 is a 4-year, 3-month-old Hispanic male who carries an approximately 317 kb deletion (minimum deletion chr1:8,509,888-8,803,072; maximum deletion chr1:8,497,191-8,813,784; hg19) 
Subject 2
Subject 2 is an 8-month-old Hispanic male who carries a de novo c.248dupA, p.(Ser84Valfs*4) variant in RERE. A nuchal translucency scan at 9 weeks and 6 days of gestation revealed a cystic hygroma. At 14 weeks of gestation, the nuchal translucency was normal at 2.2 mm.
Anatomy ultrasounds and fetal echocardiography did not identify any structural anomalies. He was born at 38 weeks of gestation via vaginal delivery. Birth weight was 2.955 kg (20th centile).
In the first months of life, he had multiple urinary tract infections.
Radiographic studies showed no evidence of hydronephrosis or vesicoureteral reflux. He was noted to be hypertonic, but his gross motor development has been normal: he rolled over at 3 months of age and started sitting on his own at 7 months of age.
At 8 months of age, his length was at the 25th centile, his weight was at the 5th centile, and his occipital frontal circumference (OFC) was at the 25th centile. On physical examination he was noted to have bifrontal narrowing, a low anterior hairline, mild hypertelorism, bilateral epicanthal folds, downslanted palpebral fissures, synophrys, mild hypoplastic helices, redundant nuchal skin, and spasticity of all four extremities with upper limbs being more affected than lower limbs.
F I G U R E 1 A-E:
Photos of Subjects 3, 5, 6 (at 6 years of age), 7 (postmortem), and 8, respectively. As previously reported, a consistent pattern of dysmorphic features is not seen among individuals with NEDBEH (Fregeau et al., 2016) . F: The locations of the RERE deletions and sequence variants reported in individuals with NEDBEH are shown in relation to the protein domains of RERE. Deletions and sequence variants found in Subjects 1-9 are shown in red if only a single variant was detected and in blue if two variants were detected. Previously published sequence variants are shown in black. A high percentage of RERE pathogenic variants affect a 21 amino acid (amino acids 1425-1445), histidine-rich region of the Atrophin-1 domain. Nucleotide (cDNA) numbering uses +1 as the A of the ATG translation initiation codon in the reference sequence, with the initiation codon as codon 1
Subject 3
Subject 3 is a 21-year-old male of European descent who carries a de novo c.4300T>C, p.(Ser1434Pro) missense variant in RERE. Pregnancy was complicated by twin gestation with loss of the second twin at 10 weeks of gestation. He was born via vaginal delivery. At birth he weighed 3.402 kg (54th centile) and was 53.3 cm (97th centile) in length. He rolled over at 6 months of age, sat at 9 months of age, crawled at 18 months of age, and walked at 3 years of age. Parents indicate that he said his first words at approximately 9 months of age and that he put two words together between 2 and 3 years of age.
He had an atrial septal defect for which he underwent a transcatheter closure and is currently being treated with atenolol for aortic root dilatation. His clinical diagnoses include developmental delay, intellectual disability, hypotonia, ataxia, obsessive compulsive disorder, expressive language disorder, bilateral ptosis, esotropia, sleep apnea, and scoliosis. A brain MRI obtained at 9 years of age revealed moderate global volume loss both supratentorially and infratentorially, a thin corpus callosum, flattening of the brain stem and a thin rim of sella. Hearing loss evaluations revealed chronic tympanic membrane perforation on the right and mild sensorineural hearing loss on the left.
At 19 years, 7 months of age his height was 163.3 cm (3rd centile) and his weight was 59.9 kg (14th centile). He was noted to have repetitive hand movements, an elongated and myopathic face with midfacial retraction, bilateral ptosis, deep-set eyes, a highly arched palate, spatulated thumbs, and hyperconvexity of his fingernails and toenails. He currently speaks in up to four to five word sentences and also uses sign language to communicate.
Subject 4
Subject 4 is a 13-year-old female of European descent who carries a de novo c.4303C>T, p.(His1435Tyr) missense variant in RERE. Pregnancy was uneventful and she was born at 39 weeks of gestation by cesarean section for breech presentation. At birth she weighed 2.980 kg (29nd centile) and was 46 cm (5th centile) long with an OFC of 35 cm (83rd centile). She had hypotonia, first noted in the neonatal period, and was ultimately diagnosed with global developmental delay and severe intellectual disability. A brain MRI obtained at 5 years of age showed hemispheric cerebellar dysplasia with abnormal lobule and fissure orientation in the inferior hemispheres. Onset of puberty was noted between 6 and 7 years of age. Treatment for precocious puberty was initiated at 8 years of age and continued until she was 13 years old.
At 13 years of age, her height was 148 cm (10th centile), her weight was 47 kg (55th centile), and her OFC was 54 cm (62nd centile). She had a vocabulary of less than 20 words and was not using two-word phrases. Hearing evaluation was normal. She has frequent temper tantrums. 
TA B L E 1 RERE deletions and sequence variants identified in Subjects
+ − + + + + N/A + + Hypotonia − − + + + − + − − Abnormal brain MRI − N/D + + − b − + N/D N
Subject 5
Subject 5 is a 22-year-old female of Japanese and European ancestry who carries a de novo c.4304A>G, p.(His1435Arg) variant in RERE. She was born by induced delivery at 40 2/7 weeks of gestation following an uneventful pregnancy. At birth she weighed 3.6 kg (78th centile), her length was 53 cm (95th centile), and her OFC was 33 cm (23rd centile).
Her Apgar scores were 8 and 9. Shortly after birth she was noted to have hypotonia and hypoxia. During her hospitalization, she was diagnosed with an atrial septal defect and found to have 11 pairs of ribs.
She was discharged home at 14 days of age with supplemental oxygen.
Global developmental delay was noted in infancy. At 1. 
Subject 6
Subject 6 is an 8-year, 6-month-old male of Asian Indian descent who carries two de novo heterozygous missense variants in RERE, a c.3292C>G, p. (Leu1098Val) PPP2R2A has a probability of loss-of-function intolerance score of 0.96 in the ExAC Browser but has not been associated with a specific genetic disorder in humans.
He was ultimately diagnosed with global developmental delay, intellectual disability, autism spectrum disorder, cerebral palsy, mild bilateral sensorineural hearing loss, bilateral myopia, and exotropia for which he had surgery. A brain MRI performed at 2 years, 1 month of age was normal.
At 8 years, 6 months of age, his height was 116.4 cm (6th centile), his weight was 22.2 kg (26th centile), and his OFC was 50.5 cm (22nd centile). On physical exam he was noted to have prominent, cupped ears, a triangular-shaped face, mild fifth finger clinodactyly, second toes that override his first toes bilaterally, and ankle valgus deformities of the feet resulting in pronation for which he wears braces.
Subject 7
Subject 7 was a male of European descent who died at 33 days of age. He carried a de novo c.4313_4318dupTCCACC, p.(Leu 1438_His1439dup) variant in RERE. This type of variant is not amenable to evaluation by PolyPhen-2 or SIFT, and MutationTaster predicts this variant to be a polymorphism. However, this duplication is located in the Atrophin-1 domain of RERE and affects a histidine-rich region whose amino acid sequence is 100% conserved down to Xenopus and zebrafish. We also note that the same variant was found to have arisen de novo in a previously reported individual with NEDBEH (Fregeau et al., 2016 ; Subject 2) and in Subject 8. Multiple punctate periventricular ischemic lesions were also detected along with restricted diffusion in the splenium of the corpus callosum.
Audiometry was not performed, but MRI and CT scans revealed normal semicircular canals.
Over time, he developed heart failure with pulmonary edema and elevated right ventricle and diastolic pressures suggestive of persistent pulmonary hypertension (> 50% systemic). He remained intubated until his death at 33 days of age. An autopsy confirmed the simplified gyration of cerebral cortex and also showed atrophy of the frontal lobes, dysplasia of the inferior olivary and dentate nuclei, mild to moderate ventriculomegaly, multifocal neuroglial heterotopia and optic nerve hypoplasia. There was also evidence of hypoxic-ischemic damage.
Subject 8
Subject 8 is an 8-year, 3-month-old female of European descent who carries a de novo c.4313_4318dupTCCACC, p. (Leu1438_His1439dup) variant in RERE. A truncus arteriosus type I defect was identified prenatally along with intrauterine growth retardation and fetal hand posturing. She was born at 39 1/7 weeks gestation by emergency cesarean section because of decreased fetal heart tones. Apgar scores were 1 and 6. Birth weight was 2.415 kg (3rd centile), length was 47 cm (13th centile) and OFC was 32 cm (6th centile).
She was subsequently diagnosed with bilateral choanal atresia, right-sided chorioretinal and iris coloboma, and anisometropia. She underwent repair of her truncus arteriosus at 1 month of age.
Following surgery, she had neonatal supraventricular tachycardia, which resolved by 1 year of age.
She has progressive sensorineural hearing loss and wears a hearing aid in the left ear and has a cochlear implant on the right side. A temporal bone CT scan showed bilateral cochlear dysplasia. She has been diagnosed with developmental delay and intellectual disability.
She has no speech and cannot stand or walk without assistance. She has short stature with advanced bone age and has been diagnosed with neuromuscular thoracolumbar scoliosis, bilateral hip dysplasia, and bilateral equinus contractures.
At 8 years, 3 months of age, her height was 114.3 cm (0.4th centile), her weight was 20.4 kg (4th centile), and her OFC was 47 cm (<1st centile). She had a flattened facial profile, hypertelorism, a right-sided iris coloboma, normally set ears with very small lobules and prominent antihelices, a broad nasal bridge, a III/VI systolic murmur and bilateral hockey stick palmar creases.
Subject 9
Subject 9 is a 4-year-old female of European descent who carries a de novo c.4391A>G, p.(His1464Arg) variant in RERE. She has a twin brother who is healthy and an older brother who was diagnosed with dyslexia but is otherwise healthy. She has been diagnosed with developmental delay, autism spectrum disorder, and obsessive compulsive disorder. Her parents report erratic behavior, extreme separation anxiety, and difficulty falling asleep and remaining asleep. At her most recent physical examination, her height and weight were at the 95th centile and her head circumference was at the 50th centile. She was found to have hirsutism affecting the back and arms, synophrys, hypertelorism, an upturned nose, and a wide mouth.
DISCUSSION
Here, we report nine individuals with NEDBEH caused by partial deletions or putatively deleterious sequence variants in RERE. Functional analyses aimed at confirming the effect of these variants on RERE function were not performed. Consistent with previous reports of individuals with NEDBEH, intellectual disability, developmental delay, and/or autism was diagnosed in all individuals except Subject 2, who is 8 months old and achieved his early motor milestones on time despite being hypertonic, and Subject 7 who died in infancy. Among the six individuals who had brain MRIs, three (50%) had structural defects, one (17%) had only mildly prominent CSF spaces, and two (33%) had MRIs that were reported as normal for age. Structural eye defects were seen in two individuals in our cohort (22%), both of whom had colobomata.
Other eye/vision problems identified included myopia, anisometropia, astigmatism, exotropia, esotropia, ptosis and optic nerve hypoplasia.
Congenital heart defects were seen in four individuals (44%) and included septal defects and truncus arteriosus.
Some of the medical problems identified in only one individual (one out of 10, 10%) in the NEDBEH cohort reported by Fregeau et al. (2016) were also identified in one or more individuals in our cohort.
These include sensorineural hearing loss, which was present in three subjects (33%), scoliosis, which was identified in two subjects (22%), and congenital hip dysplasia, which was seen in one individual (11%).
These medical problems have also been previously reported in individuals who carry 1p36 deletions that include RERE (Fregeau et al., 2016) .
TA B L E 3 Statistical comparison of the incidence of structural birth defects and sensorineural hearing loss among genotypic groups Fregeau et al. (2016) suggested that point mutations in the Atrophin-1 domain might be associated with a more severe clinical presentation. Our study provides additional evidence in support of this genotype-phenotype correlation. Among the 19 individuals with NED-BEH described here and by Fregeau et al. (2016) , six (31%) carry putative loss-of-function variants-partial deletions, nonsense variants, or frameshift variants-and 12 (63%) individuals carry point mutations in the Atrophin-1 domain. We evaluated the incidence of structural defects of the brain, eye, heart, and kidney and sensorineural hearing loss between these two groups (Table 3 and Supp. Table S1 ). The total number of structural defects and sensorineural hearing loss diagnoses seen in individuals with point mutations in the Atrophin-1 domain is significantly higher than expected based on the number of similar defects seen in individuals with putative loss-of-function variants (P = 0.0004).
Genotype-phenotype correlations
The increase in severity seen with point mutations in the Atophin-1 domain may be due to the generation of an abnormal protein product that functions in a dominant negative fashion by antagonizing the function of the wild-type gene product within the same cell. This hypothesis is supported by the fact that the phenotypes seen in individuals with point mutations overlap those of Rere om/eyes3 mice who carry both a null and a hypomorphic allele of Rere (Fregeau et al., 2016; Kim et al., 2013 Studies of RERE-deficient mice on different genetic backgrounds have shown that the penetrance of some RERE-related phenotypes, such a congenital heart defects, are highly dependent on genetic factors that have yet to be identified (Kim et al., 2013 (Fregeau et al., 2016 ; Subject 2) who had a unilateral iris coloboma, a ventricular septal defect, a patent ductus arteriosus that was surgically closed, anomalous pulmonary venous return, choanal atresia, simple ears, cryptorchidism, a right-sided multicystic kidney, short stature, microcephaly, developmental delay, and brain anomalies that included a thin corpus callosum, ventriculomegaly, incompletely folded hippocampi, and severely diminished white matter volume (Fregeau et al., 2016) .
Due to their clinical presentations, all three of these individuals were originally suspected to have CHARGE syndrome (Coloboma, Heart defects, choanal Atresia, Retarded growth and development, Genital abnormalities, and Ear anomalies), which is most commonly caused by heterozygous variants in CHD7 (Hall, 1979; Hittner, Hirsch, Kreh, & Rudolph, 1979; Vissers et al., 2004) . Indeed, all of these individuals fulfill the diagnostic criteria for CHARGE syndrome proposed by Hale, Niederriter, Green, and Martin (2016) ( Table 4) . In all cases, exome sequencing was undertaken only after screening of the CHD7 gene failed to reveal a causative variant. This suggests that consideration should be given to sequencing RERE, or testing for the c.4313_4318dupTCCACC variant, in individuals who meet diagnostic criteria for CHARGE syndrome but do not have pathogenic variants in CHD7.
Although RERE and CHD7 are not known to interact, both function to regulate the transcription of other genes and are widely expressed in the developing embryo (Bouazoune & Kingston, 2012; Lalani et al., 2006; Sanlaville et al., 2006; Zoltewicz et al., 2004) . The overlapping phenotypes seen in individuals with deficiency of RERE and CHD7 suggest that they may regulate the expression of a common set of genes in the developing embryo or that their gene targets may function in the same molecular pathways. In support of this hypothesis, we note that RERE has been show to positively regulate retinoic acid signaling during embryonic development (Kumar & Duester, 2014; Vilhais-Neto et al., 2010; Vilhais-Neto et al., 2017) . Although, CHD7 has not been shown to regulate retinoic acid signaling, modulation of retinoic acid signaling has been shown to prevent in vivo inner ear and in vitro neural stem cell defects caused by CHD7 deficiency (Micucci et al., 2014) .
In addition, RERE has also been shown to stimulate Notch target gene expression, including the expression of Hes genes, by preventing degradation of the Notch intracellular domain (Wang, Gui, Rallo, Xu, & Matise, 2017) . Similarly, CHD7 is required for the full induction of Hes5 in quiescent neural stem/progenitor cells and loss of CHD7 function leads to decreased expression of the Notch ligand JAG1 in the developing inner ear (Hurd, Micucci, Reamer, & Martin, 2012; Jones et al., 2015) . 
CONCLUSIONS
